Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Author/ Professor Chris Trimble Explains Why Reverse Innovation Is “Oxygen,” Not Optional For MNCs: An Interview With PharmAsia News (Part 2 Of 2)

This article was originally published in PharmAsia News

Executive Summary

Authors Chris Trimble and Vijay Govindarajan, professors at The Tuck School of Business at Dartmouth, coined the term ‘reverse innovation’ and recently published a book arguing why MNCs need to incorporate RI systemically into their core competitive strategies. Below, Trimble speaks to PharmAsia News on the topic and how pharma companies can relate to it.


Related Content

New Approaches To Innovation Needed To Reach Globe's Poor At The "Bottom Of The Pyramid" - And To Fend Off Emerging Competitors Around The World


Related Companies




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts